Abstract
Dual probes that possess positron emission tomography (PET) and fluorescence imaging (FI) capabilities are precision medicine tools that can be used to improve patient care and outcomes. Detecting tumor lesions using PET, an extremely sensitive technique, coupled with fluorescence-guided surgical resection of said tumor lesions can maximize the removal of cancerous tissue. The development of novel molecular probes is important for targeting different biomarkers as every individual case of cancer has different characteristics. This short review will discuss some aspects of dual PET/FI probes and explore the recently reported examples.
Author supplied keywords
Cite
CITATION STYLE
Yuen, R., West, F. G., & Wuest, F. (2022, March 1). Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer. Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics14030645
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.